ZeU Announces Warrant Extension
|
|
ZeU Technologies
|
Jun 06, 2023 09:23AM
|
Xali Gold Trading Halt
|
|
Xali Gold Corp.
|
Aug 06, 2024 07:00AM
|
Xali Gold Options High Sulphidation Gold Project in Central Peru
|
|
Xali Gold Corp.
|
Sep 05, 2024 07:00AM
|
Xali Gold Enters Agreement for Mining in Historic Underground Workings, Exploration and Reducing Debt at El Oro Mexico
|
|
Xali Gold Corp.
|
Jul 22, 2024 07:00AM
|
Xali Gold Advances on Two Fronts at El Oro
|
|
Xali Gold Corp.
|
Aug 28, 2024 07:00AM
|
With World Record In Sight, HPQ Silicon Groundbreaking Advancement in Li-Ion Battery Tech Unleashes $130B Silicon Anode Market Potential
|
7
|
HPQ Silicon Inc.
|
May 27, 2024 11:24AM
|
With Two New Behavioral Health Customers, SOBRsafe has Now Secured 20 New Accounts in 2024
|
|
SOBR Safe Inc.
|
May 14, 2024 08:00AM
|
With New Four-Facility Customer, SOBRsafe Enters Florida - a Key Behavioral Health Market
|
|
SOBR Safe Inc.
|
Apr 17, 2024 08:00AM
|
With $14M + In Contracts YTD Cloud DX Dominates Canada's Remote Patient Monitoring Market
|
|
Cloud DX Inc.
|
May 27, 2024 11:10AM
|
VOLUME ALERT: SOBRSafe (SOBR: NASDAQ) Up 9% On 65.2M Shares
|
|
SOBR Safe Inc.
|
Jun 27, 2024 04:00PM
|
Video: SOBRsafe CEO Recaps Debut Year, Gives Perspective on 2023 in Comprehensive Interview
|
|
SOBR Safe Inc.
|
Jan 13, 2023 08:00AM
|
Video Update: SOBRsafe CEO Dave Gandini Discusses Evolved Sales Focus and 2024 Strategy
|
|
SOBR Safe Inc.
|
Apr 16, 2024 09:00AM
|
Valeo Pharma to Webcast Live at Virtual Investor Conference March 9th
|
|
Valeo Pharma Inc.
|
Mar 06, 2023 08:35AM
|
VALEO PHARMA TO HOST FOURTH QUARTER AND YEAR-END 2022 RESULTS CONFERENCE CALL / WEBCAST
|
|
Valeo Pharma Inc.
|
Jan 25, 2023 09:38AM
|
VALEO PHARMA TO HOST FIRST QUARTER 2023 RESULTS CONFERENCE CALL / WEBCAST
|
|
Valeo Pharma Inc.
|
Mar 09, 2023 07:00AM
|
Valeo Pharma sees record quarterly revenue with a triple-digit increase over 1Q 2022
|
|
Valeo Pharma Inc.
|
Mar 17, 2023 11:40AM
|
VALEO PHARMA REPORTS RECORD QUARTERLY REVENUES FOR THE FIRST QUARTER 2023
|
|
Valeo Pharma Inc.
|
Mar 15, 2023 05:00PM
|
VALEO PHARMA REPORTS RECORD QUARTERLY AND ANNUAL REVENUES FOR THE FOURTH QUARTER AND THE FISCAL YEAR 2022
|
|
Valeo Pharma Inc.
|
Jan 30, 2023 05:03PM
|
VALEO PHARMA RAISES Q4 AND FULL YEAR 2022 REVENUE GUIDANCE
|
|
Valeo Pharma Inc.
|
Nov 15, 2022 07:00AM
|
VALEO PHARMA OBTAINS PUBLIC REIMBURSEMENT FOR ONSTRYV® IN QUEBEC
|
|
Valeo Pharma Inc.
|
Feb 07, 2023 07:00AM
|